Trial Condition(s):

Multiple Sclerosis

Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis

Bayer Identifier:

308272

ClinicalTrials.gov Identifier:

NCT00206635

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The purpose of this follow-up study is to look carefully at the long-term course of multiple sclerosis (MS) and possibly the long-term effects of Betaseron in the patients who were previously enrolled in the original North American study that led to the marketing approval of Betaseron.

Inclusion Criteria
- Patients in North America have to have been previously enrolled in the original Betaseron trial from 1988-1993 
 - Be able to understand the consent form (or have a guardian who can)
Exclusion Criteria
- North American patients cannot be included if they have not participated in the original Betaseron trial from 1988-1993

Trial Summary

Enrollment Goal
432
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Betaseron (Interferon beta-1b, BAY86-5046)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Canada

Status
Completed
 
Locations

Investigative Site

Many Locations, Canada

Status
Completed
 
Locations

Investigative Site

Many Locations, Canada

Status
Completed
 
Locations

Investigative Site

Many Locations, United States

Status
Completed
 
Locations

Investigative Site

Many Locations, United States

Status
Completed
 
Locations

Investigative Site

Many Locations, United States

Status
Completed
 
Locations

Investigative Site

Many Locations, United States

Status
Completed
 
Locations

Investigative Site

Many Locations, United States

Status
Completed
 
Locations

Investigative Site

Many Locations, United States

Status
Completed
 

Trial Design